(Q36981682)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Curtis Cooper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1731-1737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B: global importance and need for control

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

The burden of hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

Nationwide vaccination: a success story in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

A hepatitis B vaccine formulated with a novel adjuvant system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

The ventilatory response to hypoxia: how much is good for a mountaineer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1731

10.1517/14712598.7.11.1731

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17961095%20AND%20SRC:MED&resulttype=core&format=json

release_oegykev7ijac5mq4n6c7pkukou

9 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oegykev7ijac5mq4n6c7pkukou

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference